100 related articles for article (PubMed ID: 12145687)
1. SHP-1 expression in peripheral T cells from patients with Sezary syndrome and in the T cell line HUT-78: implications in JAK3-mediated signaling.
León F; Cespón C; Franco A; Lombardía M; Roldán E; Escribano L; Harto A; González-Porqué P; Roy G
Leukemia; 2002 Aug; 16(8):1470-7. PubMed ID: 12145687
[TBL] [Abstract][Full Text] [Related]
2. Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter.
Zhang Q; Raghunath PN; Vonderheid E; Odum N; Wasik MA
Am J Pathol; 2000 Oct; 157(4):1137-46. PubMed ID: 11021818
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor beta chain.
Adachi M; Ishino M; Torigoe T; Minami Y; Matozaki T; Miyazaki T; Taniguchi T; Hinoda Y; Imai K
Oncogene; 1997 Apr; 14(13):1629-33. PubMed ID: 9129156
[TBL] [Abstract][Full Text] [Related]
4. IL-2, but not IL-4 and other cytokines, induces phosphorylation of a 98-kDa protein associated with SHP-2, phosphatidylinositol 3'-kinase, and Grb2.
Gadina M; Sudarshan C; O'Shea JJ
J Immunol; 1999 Feb; 162(4):2081-6. PubMed ID: 9973481
[TBL] [Abstract][Full Text] [Related]
5. Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells.
Migone TS; Cacalano NA; Taylor N; Yi T; Waldmann TA; Johnston JA
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3845-50. PubMed ID: 9520455
[TBL] [Abstract][Full Text] [Related]
6. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
8. Abnormal splicing of SHP-1 protein tyrosine phosphatase in human T cells. Implications for lymphomagenesis.
Ma XZ; Jin T; Sakac D; Fahim S; Zhang X; Katsman Y; Bali M; Branch DR
Exp Hematol; 2003 Feb; 31(2):131-42. PubMed ID: 12591278
[TBL] [Abstract][Full Text] [Related]
9. Transcript synthesis and surface expression of the interleukin-2 receptor (alpha-, beta-, and gamma-chain) by normal and malignant myeloid cells.
Schumann RR; Nakarai T; Gruss HJ; Brach MA; von Arnim U; Kirschning C; Karawajew L; Ludwig WD; Renauld JC; Ritz J; Herrmann F
Blood; 1996 Mar; 87(6):2419-27. PubMed ID: 8630406
[TBL] [Abstract][Full Text] [Related]
10. STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
Brender C; Nielsen M; Kaltoft K; Mikkelsen G; Zhang Q; Wasik M; Billestrup N; Odum N
Blood; 2001 Feb; 97(4):1056-62. PubMed ID: 11159537
[TBL] [Abstract][Full Text] [Related]
11. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
Paling NR; Welham MJ
Biochem J; 2002 Dec; 368(Pt 3):885-94. PubMed ID: 12220225
[TBL] [Abstract][Full Text] [Related]
12. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
[TBL] [Abstract][Full Text] [Related]
13. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
14. Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation.
Dustin LB; Plas DR; Wong J; Hu YT; Soto C; Chan AC; Thomas ML
J Immunol; 1999 Mar; 162(5):2717-24. PubMed ID: 10072516
[TBL] [Abstract][Full Text] [Related]
15. Defective expression of the SHP-1 phosphatase in polycythemia vera.
Wickrema A; Chen F; Namin F; Yi T; Ahmad S; Uddin S; Chen YH; Feldman L; Stock W; Hoffman R; Platanias LC
Exp Hematol; 1999 Jul; 27(7):1124-32. PubMed ID: 10390187
[TBL] [Abstract][Full Text] [Related]
16. Gab2 is phosphorylated on tyrosine upon interleukin-2/interleukin-15 stimulation in mycosis-fungoides-derived tumor T cells and associates inducibly with SHP-2 and Stat5a.
Brockdorff JL; Gu H; Mustelin T; Kaltoft K; Geisler C; Röpke C; Ødum N
Exp Clin Immunogenet; 2001; 18(2):86-95. PubMed ID: 11340297
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of the protein tyrosine phosphatase SHP-1 in oligodendrocytes.
Massa PT; Saha S; Wu C; Jarosinski KW
Glia; 2000 Feb; 29(4):376-85. PubMed ID: 10652447
[TBL] [Abstract][Full Text] [Related]
18. SHP-1 dephosphorylates 3BP2 and potentially downregulates 3BP2-mediated T cell antigen receptor signaling.
Yu Z; Maoui M; Zhao ZJ; Li Y; Shen SH
FEBS J; 2006 May; 273(10):2195-205. PubMed ID: 16649996
[TBL] [Abstract][Full Text] [Related]
19. The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells.
Suárez Pestana E; Tenev T; Gross S; Stoyanov B; Ogata M; Böhmer FD
Oncogene; 1999 Jul; 18(28):4069-79. PubMed ID: 10435588
[TBL] [Abstract][Full Text] [Related]
20. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]